Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedMay 22, 2022
DataAggregated Company Financials
Companies7
  • 7D3.2%
  • 3M-46.1%
  • 1Y-64.3%
  • YTD-38.5%

The Biotech industry is up 3.2% in the last week, with Idorsia up 3.6%. In the same time, Addex Therapeutics was down 11%. However, the industry is down 64% over the past year. Looking forward, earnings are forecast to decline by 38% per year.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 22 May 2022CHF719.6mCHF471.4mCHF25.1m2.1x
Tue, 19 Apr 2022CHF1.1bCHF291.9m-CHF142,532,527.001.9x
Thu, 17 Mar 2022CHF1.2bCHF285.6m-CHF140,575,871.001.9x
Sat, 12 Feb 2022CHF1.4bCHF282.9m-CHF138,870,474.001.8x
Mon, 10 Jan 2022CHF4.7bCHF317.7m-CHF658,979,620.001.5x
Wed, 08 Dec 2021CHF3.8bCHF319.1m-CHF658,785,712.001.5x
Fri, 05 Nov 2021CHF4.3bCHF315.2m-CHF658,961,084.002.3x
Sun, 03 Oct 2021CHF5.1bCHF288.3m-CHF590,726,662.004.9x
Tue, 31 Aug 2021CHF5.2bCHF306.0m-CHF612,309,374.801.1x
Wed, 07 Jul 2021CHF5.8bCHF306.0m-CHF612,309,374.801.1x
Sat, 10 Apr 2021CHF6.2bCHF352.3m-CHF535,605,963.803.8x
Fri, 01 Jan 2021CHF6.1bCHF407.2m-CHF561,055,198.507.1x
Mon, 05 Oct 2020CHF5.7bCHF399.6m-CHF565,530,866.501x
Thu, 09 Jul 2020CHF4.9bCHF393.6m-CHF565,357,804.5030x
Wed, 01 Apr 2020CHF788.5mCHF327.2m-CHF114,875,385.506.6x
Sat, 04 Jan 2020CHF4.6bCHF460.8m-CHF670,400,644.00n/a
Tue, 08 Oct 2019CHF3.9bCHF473.1m-CHF646,955,470.00n/a
Mon, 01 Jul 2019CHF3.6bCHF449.1m-CHF654,647,900.00n/a
Median PE Ratio

n/a


Total Market Cap: CHF3.7bTotal Earnings: -CHF598,220,488.00Total Revenue: CHF451.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Median PE3Y Average 17.4x202020212022
Current Industry PEThere are only 2 profitable companies in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable.
  • Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-2.84%
Healthcare0.093%
Biotech3.15%
Biotech3.15%
Industry PE
  • Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 24.2x.
  • Analysts are expecting annual earnings decline of 38%, which is lower than the prior year's growth of 52% per year.
  • This could indicate that the market believes that analysts are underestimating future growth or they expect the Biotech industry's earnings to deteriorate the least compared to other industries.
Forecasted Growth
  • Despite it being negative, analysts are least pessimistic on the Biotech industry since they expect its earnings to decline by only 38% per year over the next 5 years, which isn't as bad as the other industries.
  • This is a reversal from its past annual earnings growth rate of 52% per year.

    Top Stock Gainers and Losers

    Which companies have driven the market over the last 7 days?

    CompanyLast Price7D1YValuation
    IDIA IdorsiaCHF15.173.6%
    +CHF93.9m
    -35.2%PS79.8x
    BSLN Basilea PharmaceuticaCHF32.605.0%
    +CHF18.4m
    -26.3%PS2.6x
    RLF Relief Therapeutics HoldingCHF0.0566.4%
    +CHF14.0m
    -73.2%PS70.3x
    MOLN Molecular PartnersCHF7.285.5%
    +CHF12.4m
    -69.2%PS2.2x
    SANN Santhera Pharmaceuticals HoldingCHF1.334.7%
    +CHF2.2m
    -40.6%PS4.1x
    Simply Wall St
    Simply Wall Street Pty Ltd
    17-21 Bellevue Street, Surry Hills, Sydney
    Download on the App StoreGet it on Google Play
    Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

    Latest News

    IDIA

    CHF15.17

    Idorsia

    7D

    3.6%

    1Y

    -35.2%

    SPEX

    CHF1.05

    Spexis

    7D

    -4.5%

    1Y

    n/a